<SEC-DOCUMENT>0001274737-25-000003.txt : 20250113
<SEC-HEADER>0001274737-25-000003.hdr.sgml : 20250113
<ACCEPTANCE-DATETIME>20250113080039
ACCESSION NUMBER:		0001274737-25-000003
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20250112
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250113
DATE AS OF CHANGE:		20250113

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			EXAGEN INC.
		CENTRAL INDEX KEY:			0001274737
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MEDICAL LABORATORIES [8071]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39049
		FILM NUMBER:		25524873

	BUSINESS ADDRESS:	
		STREET 1:		1261 LIBERTY WAY
		CITY:			VISTA
		STATE:			CA
		ZIP:			92081
		BUSINESS PHONE:		(760) 560-1501

	MAIL ADDRESS:	
		STREET 1:		1261 LIBERTY WAY
		CITY:			VISTA
		STATE:			CA
		ZIP:			92081

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	EXAGEN DIAGNOSTICS INC
		DATE OF NAME CHANGE:	20031230
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>exdx-20250112.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:13b084dd-9e50-4512-9a96-af0b9b23f94f,g:54378a50-3915-4b54-bf80-392c104a8525,d:dff5112850314b398efb04b6d115ad77-->
<html xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns="http://www.w3.org/1999/xhtml" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xbrli="http://www.xbrl.org/2003/instance" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>exdx-20250112</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-21">0001274737</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" format="ixt:fixed-false" id="f-22">FALSE</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="exdx-20250112.xsd"/></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001274737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-12</xbrli:startDate><xbrli:endDate>2025-01-12</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="idff5112850314b398efb04b6d115ad77_1"></div><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C. 20549 </span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">8-K</ix:nonNumeric> </span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CURRENT REPORT </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Pursuant to Section 13 or 15(d) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">of the Securities Exchange Act of 1934 </span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Date of Report (Date of earliest event reported): <ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-2">January 12, 2025</ix:nonNumeric> </span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:24pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-3">EXAGEN INC.</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter) </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.071%"><tr><td style="width:1.0%"/><td style="width:32.886%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.107%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:30.599%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.107%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:30.601%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-4">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-5">001-39049</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-6">20-0434866</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(State or other jurisdiction</span></div><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">of incorporation)</span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Commission</span></div><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">File Number)</span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(IRS Employer</span></div><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Identification No.)</span></div></td></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-7">1261 Liberty Way</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-8">Vista</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" id="f-9">CA</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-10">92081</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Address of principal executive offices) (Zip Code) </span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-11">760</ix:nonNumeric>) <ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-12">560-1501</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Registrant&#8217;s telephone number, including area code) </span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">N/A </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Former Name or Former Address, if Changed Since Last Report) </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"/><td style="width:2.749%"/><td style="width:0.1%"/><td style="width:0.0%"/><td style="width:0.140%"/><td style="width:0.0%"/><td style="width:1.0%"/><td style="width:81.765%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.946%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:WrittenCommunications" format="ixt:fixed-false" id="f-13">&#9744;</ix:nonNumeric></span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SolicitingMaterial" format="ixt:fixed-false" id="f-14">&#9744;</ix:nonNumeric></span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementTenderOffer" format="ixt:fixed-false" id="f-15">&#9744;</ix:nonNumeric></span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementIssuerTenderOffer" format="ixt:fixed-false" id="f-16">&#9744;</ix:nonNumeric></span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.679%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:28.959%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.682%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Trading</span></div><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Symbol(s)</span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Name of each exchange</span></div><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">on which registered</span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-17">Common Stock, par value $0.001 per share</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-18">XGN</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-19">The Nasdaq Global Market</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter). Emerging growth company </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="f-20">&#9744;</ix:nonNumeric> </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#9744; </span></div><div><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.02&#160;&#160;&#160;&#160;Results of Operations and Financial Condition. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 12, 2025, Exagen Inc. (the &#8220;Company&#8221;) announced in a press release (the &#8220;Press Release&#8221;) certain select preliminary unaudited financial information and results of operations for the three months and year ended December 31, 2024, based on currently available information. A copy of the Press Release issued by the Company is furnished as Exhibit 99.1 to this Current Report on Form 8-K. The Company&#8217;s financial closing procedures with respect to the select preliminary unaudited financial information and results of operations provided in the Press Release are not yet complete. These procedures often result in changes to accounts. As a result, the Company&#8217;s final results may vary from the preliminary results and information presented in the Press Release. The Company undertakes no obligation to update or supplement the information and presented in the Press Release until it releases its financial statements for the three months and year ended December 31, 2024.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The select preliminary unaudited financial information and results of operations included in this Current Report on Form 8-K and in the Press Release have been prepared by, and are the responsibility of, the Company. BDO USA, P.C. (&#8220;BDO&#8221;) has not audited, reviewed, compiled, or applied agreed-upon procedures with respect to the select preliminary unaudited financial information and results of operations included in the Press Release and this Current Report on Form 8-K. Accordingly, BDO does not express an opinion or any other form of assurance with respect to this information. The information provided in this Item 2.02 of this Current Report on Form 8-K shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as expressly set forth by specific reference in such filing or in this Current Report on Form 8-K.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 8.01&#160;&#160;&#160;&#160;Other Events. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following information contained in the Press Release is deemed &#8220;filed&#8221; for purposes of Section 18 of the Exchange Act and deemed incorporated by reference into this Item 8.01:</span></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The information included under the headings &#8220;Preliminary Unaudited Select Financial Results,&#8221; &#8220;Cautionary Note Regarding Select Preliminary Unaudited Financial Results,&#8221; &#8220;Use of Unaudited Non-GAAP Financial Measures,&#8221; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reconciliation of Non-GAAP Financial Measures (UNAUDITED)&#8221; and &#8220;Forward Looking Statements.&#8221;</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9.01&#160;&#160;&#160;&#160;Financial Statements and Exhibits. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) Exhibits </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:7.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.215%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:86.103%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit No.</span></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"><div><span><br/></span></div></td><td colspan="6" style="padding:0 1pt"><div><span><br/></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.1</span></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="pressrelease-2024selectpre.htm">Press Release dated January </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="pressrelease-2024selectpre.htm">12</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="pressrelease-2024selectpre.htm">, 202</a>5</span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="6" style="padding:0 1pt"><div><span><br/></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SIGNATURES </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.220%"><tr><td style="width:1.0%"/><td style="width:43.108%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.105%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.652%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.105%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.978%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.105%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:42.947%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EXAGEN INC.</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="6" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="6" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="6" style="padding:0 1pt"><div><span><br/></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: January 13, 2025</span></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Jeffrey G. Black</span></td></tr><tr><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jeffrey G. Black</span></td></tr><tr><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</span></td></tr></table></div><div><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>pressrelease-2024selectpre.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="iadc3c67dabcd417d98152f9b6232915f_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:8pt"><img alt="imagea.jpg" src="imagea.jpg" style="height:48px;margin-bottom:5pt;vertical-align:text-bottom;width:152px"></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:700;line-height:125%">Exagen Inc. Secures Conditional NY State Approval for New Lupus and Rheumatoid Arthritis Biomarkers and Announces Select Preliminary 2024 Financial Results </font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-style:italic;font-weight:400;line-height:125%">New biomarkers on track for commercial launch in January 2025 </font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-style:italic;font-weight:400;line-height:125%">Preliminary financial results indicate record full-year revenue and AVISE CTD trailing twelve-month ASP, with improvements to adjusted EBITDA and cash burn</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">January 12, 2025 </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:150%">Carlsbad, CA&#8212;Exagen Inc. (Nasdaq&#58; XGN), a leading provider of autoimmune testing, today announced it has received conditional approval from the New York State Department of Health for its new systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) biomarker assays, with a planned commercial launch in January 2025.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:150%">  </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:150%">The company also announced preliminary unaudited select financial results for the fourth quarter and full year ended December 31, 2024, in line with prior financial guidance.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:112%">New AVISE CTD Biomarkers</font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:150%">The company&#8217;s new SLE and RA biomarkers will be incorporated into the AVISE CTD platform. Collectively, the company expects these new biomarkers will further improve the clinical utility of AVISE CTD, and provide clinicians with the information they need to definitively diagnose patients and shorten their autoimmune diagnostic journeys.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">The new biomarkers are as follows&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:150%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:150%;padding-left:13.8pt">T-Cell Lupus profile comprises new biomarkers&#59; TC4d, TIgG, and TIgM.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:150%"> These markers provide superior sensitivity for SLE compared to conventional SLE biomarkers, further enhancing our industry-leading AVISE Lupus profile for a more comprehensive diagnosis, particularly in clinically ambiguous cases.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:150%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:150%;padding-left:12.03pt">RA profile includes additional anti-RA33 biomarkers&#59; IgA, IgG, and IgM.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:150%"> These markers provide clinicians with more data to confidently identify patients with RA and substantiate a seronegative RA diagnosis.</font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:150%">Preliminary Unaudited Select Financial Results </font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.133%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br>December 31, 2024</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended<br>December 31, 2024</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions, except trailing 12-month average selling price)</font></td><td colspan="3" style="padding:0 1pt 0 19pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revenue</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$13.3 to $13.8</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$55.3 to $55.8</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net Loss</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">($3.4) to ($4.4)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">($14.8) to ($15.8)</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjusted EBITDA</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">($2.2) to ($3.2)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">($9.8) to ($10.8) </font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">AVISE CTD Trailing 12-month average selling price</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$408 to $412</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$408 to $412</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$22.2</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$22.2</font></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:150%">The preliminary unaudited select financial results reported today represent&#58;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:150%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:150%;padding-left:13.8pt">Record full-year 2024 revenue and AVISE CTD ASP</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:150%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:150%;padding-left:13.8pt">AVISE CTD trailing twelve-month ASP improvement of $72 to $76 compared to Q4 2023</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:150%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:150%;padding-left:13.8pt">Full-year 2024 adjusted EBITDA improvement of to 37% to 43% compared to full-year 2023</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:150%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:150%;padding-left:13.8pt">Net neutral cash usage in the fourth quarter of 2024</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:150%">&#8220;2024 was a remarkable year for Exagen by many accounts. We reached a significant milestone by testing our 1,000,000</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:150%;position:relative;top:-3.5pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:150%"> patient with AVISE CTD, an impressive achievement for any proprietary test, but especially one in a field that hasn&#8217;t seen robust biomarker innovation for many decades,&#8221; said John Aballi, CEO. </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:150%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:150%">&#8220;We&#8217;ve also made great strides in optimizing our company&#8217;s operations and continued our progress toward profitability - a goal which is now firmly within reach, all while delivering record reimbursement per test and record overall revenue performance.&#34;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:150%">Mr. Aballi continued, &#8220;To start 2025 with New York State&#8217;s approval of our new assays is another significant milestone, and we now sit in the midst of several growth catalysts with strong momentum to start the year. I&#8217;m very grateful to the dedicated team we have, and couldn&#8217;t be more excited about what lies ahead.&#8221; </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Cautionary Note Regarding Select Preliminary Unaudited Financial Results</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:150%">The company is providing the above preliminary unaudited select financial information and results of operations as of and for the three months and year ended December 31, 2024, based on currently available information. The company&#8217;s financial closing procedures with respect to the estimated financial data provided above are not yet complete. These procedures often result in changes to accounts. Our independent registered public accounting firm has not audited, reviewed, compiled or performed any procedures with respect to the preliminary unaudited select financial information and, accordingly, our independent registered public accounting firm does not express an opinion or any other form of assurance with respect thereto. As a result, the company&#8217;s final results may vary from the preliminary results presented above. Management undertakes no obligation to update or supplement the information provided above until it releases its audited financial statements prepared in accordance with U.S. Generally Accepted Accounting Principles (GAAP) for the year ended December 31, 2024.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Use of Unaudited Non-GAAP Financial Measures </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:150%">In addition to the financial results prepared in accordance with GAAP, this press release contains the metric adjusted EBITDA, which is not calculated in accordance with GAAP and is a non-GAAP financial measure. Adjusted EBITDA excludes from net loss interest income (expense), income tax expense (benefit), depreciation and amortization expense, stock-based compensation expense and other expenses or income that management believes are not representative of the company&#8217;s operations.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:150%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:150%">Such items could have a significant impact on the calculation of GAAP net loss. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:150%">The table below presents the reconciliation of preliminary net loss to adjusted EBITDA, which is a non-GAAP financial measure. See &#34;Use of Non-GAAP Financial Measures (UNAUDITED)&#34; above for further information regarding the company's use of non-GAAP financial measures.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:150%">Reconciliation of Non-GAAP Financial Measures (UNAUDITED)</font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:58.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.161%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.164%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br>December 31, 2024</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended<br>December 31, 2024</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Adjusted EBITDA</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">($3.4) to ($4.4)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">($14.8) to ($15.8)</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other (Income) Expense</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">($0.2)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">($0.8)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest Expense</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$0.6</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$2.3</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation and amortization expense</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$0.4</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$1.7</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation expense</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$0.4</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$1.8</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjusted EBITDA (Non-GAAP)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">($2.2) to ($3.2)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">($9.8) to ($10.8)</font></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:150%">Management believes that this non-GAAP financial measure, taken in conjunction with GAAP financial measures, provides useful information for both management and investors by excluding certain non-cash and other expenses that are not indicative of the company&#8217;s core operating results. Management uses non-GAAP measures to compare the company&#8217;s performance relative to forecasts and strategic plans and to benchmark the company&#8217;s performance externally against competitors. However, this non-GAAP financial measure may be different from non-GAAP financial measures used by other companies, even when the same or similarly titled terms are used to identify such measures, limiting their usefulness for comparative purposes. Non-GAAP information is not prepared under a comprehensive set of accounting rules and should only be used to supplement an understanding of the company&#8217;s operating results as reported under U.S. GAAP.</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:150%">This non-GAAP financial measure is not meant to be considered in isolation or used as a substitute for net loss reported in accordance with GAAP, should be considered in conjunction with financial information presented in accordance with GAAP, has no standardized meaning prescribed by GAAP, is unaudited, and is not prepared under any comprehensive set of accounting rules or principles. In addition, from time to time in the future, there may be other items that management may exclude for purposes of this non-GAAP financial measure, and may in the future cease to exclude items that historically have been excluded for purposes of this non-GAAP financial measure. Likewise, management may determine to modify the nature of adjustments to arrive at this non-GAAP financial measure. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">About Exagen</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:150%">Exagen Inc. (Nasdaq&#58; XGN) is a leading provider of autoimmune diagnostics, committed to transforming care for patients with chronic and debilitating autoimmune conditions. Based in San Diego County, California, Exagen&#8217;s mission is to provide clarity in autoimmune disease decision making and improve clinical outcomes through its innovative testing portfolio. The company&#8217;s flagship product, AVISE&#174; CTD, enables clinicians to more effectively diagnose complex autoimmune conditions such as lupus, rheumatoid arthritis, and Sj&#246;gren&#8217;s syndrome earlier and with greater accuracy. Exagen&#8217;s laboratory specializes in the testing of rheumatic diseases, delivering precise and timely results, supported by a full suite of AVISE-branded tests for disease diagnosis, prognosis, and monitoring. With a focus on research, innovation, education, and patient-centered care, Exagen is dedicated to addressing the ongoing challenges of autoimmune disease management.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">For more information, please visit Exagen.com or follow &#64;ExagenInc on X (formerly known as Twitter).</font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Forward Looking Statements</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:150%">Exagen cautions you that statements contained in this press release regarding matters that are not historical facts are forward-looking statements. These statements are based on Exagen&#8217;s current beliefs and expectations. Such forward-looking statements include, but are not limited to, statements regarding&#58; Exagen&#8217;s goals, strategies and ambitions&#59; the potential utility and effectiveness of Exagen&#8217;s services and testing solutions, including the newly approved SLE and RA biomarkers&#59; potential shareholder value and growth and profitability&#59; preliminary financial information as of and for December 31, 2024&#59; and guidance. The inclusion of forward-looking statements should not be regarded as a representation by Exagen that any of its plans will be achieved. Actual results may differ from those set forth in this press release due to the risks and uncertainties inherent in Exagen&#8217;s business, including, without limitation&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:150%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:150%">delays in reimbursement and coverage decisions from Medicare and third-party payors and in interactions with regulatory authorities, and delays in ongoing and planned clinical trials involving its tests&#59; Exagen&#8217;s commercial success depends upon attaining and maintaining significant market acceptance of its testing products among rheumatologists, patients, third-party payors and others in the medical community&#59; Exagen&#8217;s ability to successfully execute on its business strategies&#59; third-party payors not providing coverage and adequate reimbursement for Exagen&#8217;s testing products, including Exagen&#8217;s ability to collect on funds due&#59; Exagen&#8217;s ability to obtain and maintain intellectual property protection for its testing products&#59; regulatory developments affecting Exagen&#8217;s business&#59; and other risks described in Exagen&#8217;s prior press releases and Exagen&#8217;s filings with the Securities and Exchange Commission (SEC), including under the heading &#8220;Risk Factors&#8221; in Exagen&#8217;s Annual Report on Form 10-K for the year ended December 31, 2023, filed with the SEC on March 18, 2024 and any subsequent filings with the SEC. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof, and Exagen undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date hereof. All forward-looking statements are qualified in their entirety by this cautionary statement, which is made under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Contact&#58;</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Ryan Douglas</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Exagen Inc.</font></div><div><font style="color:#0563c1;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">ir&#64;exagen.com</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">760.560.1525</font></div><div><font><br></font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>exdx-20250112.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:13b084dd-9e50-4512-9a96-af0b9b23f94f,g:54378a50-3915-4b54-bf80-392c104a8525-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:exdx="http://www.exagen.com/20250112" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.exagen.com/20250112">
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="exdx-20250112_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="exdx-20250112_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.exagen.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>exdx-20250112_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:13b084dd-9e50-4512-9a96-af0b9b23f94f,g:54378a50-3915-4b54-bf80-392c104a8525-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_36f35ff0-2b86-4ea2-afbc-23d3b318b2a2_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_9f475f85-0463-4232-b537-5a51af2f0631_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_5e213263-0139-4fda-b811-bbbc5bc04df2_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_adfab5a0-502d-4a18-b0b8-1b2b51d4f270_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_e099533a-7b37-40f2-bced-d6415c5a17f9_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_570a02d9-bc5e-42b2-bead-fce07ee702c8_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_0b9c000c-021f-400b-a898-5cf9d50ac305_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_8f2e8dd8-37de-4361-b514-0160956685e4_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_bce27a9c-92be-4578-86ed-e0fa776cc620_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_f8a99746-5365-4eb9-81b2-2a9827c048cf_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_b8941014-f082-4bcf-aef8-3fa942a17880_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_4b3dde86-2f5b-43cb-934b-71301d8a3b75_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_cf6910cc-0907-44aa-ade7-3cfe0ef15f33_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_6b177e90-00e4-4bb8-9e0c-a8ab9ec9725d_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_e40acc5a-38d4-4e93-aee8-4ce84ca7f2cf_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_95fa3954-6ed4-42a7-a40b-2fd1c0276261_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_d404f8eb-16d5-4228-9c5e-41a5d5534587_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_d2785c43-8413-4479-99f5-bdac091d7074_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_292677f0-da3b-44c1-b1f7-16714789f28e_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_4a3e7447-5706-4b18-b4e4-23655c0ad1a3_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_1047bde3-3d7a-4e59-afeb-4b713623785e_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_853c4d9b-b9d3-41f1-90cc-b060c4d1e026_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>exdx-20250112_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:13b084dd-9e50-4512-9a96-af0b9b23f94f,g:54378a50-3915-4b54-bf80-392c104a8525-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.exagen.com/role/Cover" xlink:type="simple" xlink:href="exdx-20250112.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.exagen.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_f9eb9e2d-88fa-4974-bb68-f31ba4031784" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_5240cbe6-b0d0-4632-bfa0-eb8c9835cb5e" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f9eb9e2d-88fa-4974-bb68-f31ba4031784" xlink:to="loc_dei_DocumentType_5240cbe6-b0d0-4632-bfa0-eb8c9835cb5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_19868455-954f-489b-ae0e-8831ad89c52e" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f9eb9e2d-88fa-4974-bb68-f31ba4031784" xlink:to="loc_dei_DocumentPeriodEndDate_19868455-954f-489b-ae0e-8831ad89c52e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_b6e77f31-cfde-446e-bcb5-0cb52b892599" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f9eb9e2d-88fa-4974-bb68-f31ba4031784" xlink:to="loc_dei_EntityRegistrantName_b6e77f31-cfde-446e-bcb5-0cb52b892599" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_a263adb5-ce91-4b6d-83d0-48282ceeddea" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f9eb9e2d-88fa-4974-bb68-f31ba4031784" xlink:to="loc_dei_EntityIncorporationStateCountryCode_a263adb5-ce91-4b6d-83d0-48282ceeddea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_e6a5505a-66b7-44bf-99ca-361dc3cd7b11" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f9eb9e2d-88fa-4974-bb68-f31ba4031784" xlink:to="loc_dei_EntityFileNumber_e6a5505a-66b7-44bf-99ca-361dc3cd7b11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_8347a453-a671-4a7a-9ff4-bbb1435f2cea" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f9eb9e2d-88fa-4974-bb68-f31ba4031784" xlink:to="loc_dei_EntityTaxIdentificationNumber_8347a453-a671-4a7a-9ff4-bbb1435f2cea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_d9e737df-589b-473e-8637-c894a0037454" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f9eb9e2d-88fa-4974-bb68-f31ba4031784" xlink:to="loc_dei_EntityAddressAddressLine1_d9e737df-589b-473e-8637-c894a0037454" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_3cba6806-bdf3-4656-970f-5f3893e73482" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f9eb9e2d-88fa-4974-bb68-f31ba4031784" xlink:to="loc_dei_EntityAddressCityOrTown_3cba6806-bdf3-4656-970f-5f3893e73482" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_d1675fe3-9f24-414c-90a7-f526fd1b7aa1" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f9eb9e2d-88fa-4974-bb68-f31ba4031784" xlink:to="loc_dei_EntityAddressStateOrProvince_d1675fe3-9f24-414c-90a7-f526fd1b7aa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_fb29f16c-d746-40f0-8be3-564135df9393" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f9eb9e2d-88fa-4974-bb68-f31ba4031784" xlink:to="loc_dei_EntityAddressPostalZipCode_fb29f16c-d746-40f0-8be3-564135df9393" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_169d6c3c-1e89-4fc7-aba2-d5b20156eda7" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f9eb9e2d-88fa-4974-bb68-f31ba4031784" xlink:to="loc_dei_CityAreaCode_169d6c3c-1e89-4fc7-aba2-d5b20156eda7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_42f92409-10dd-4c30-89bc-45f94117afbb" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f9eb9e2d-88fa-4974-bb68-f31ba4031784" xlink:to="loc_dei_LocalPhoneNumber_42f92409-10dd-4c30-89bc-45f94117afbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_15163e16-00d6-4c96-bc62-4c6d65eed44c" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f9eb9e2d-88fa-4974-bb68-f31ba4031784" xlink:to="loc_dei_WrittenCommunications_15163e16-00d6-4c96-bc62-4c6d65eed44c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_01e3c919-8639-4329-8c91-53123e2fcd6e" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f9eb9e2d-88fa-4974-bb68-f31ba4031784" xlink:to="loc_dei_SolicitingMaterial_01e3c919-8639-4329-8c91-53123e2fcd6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_81f57f25-d754-44a0-b579-202c9021d38e" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f9eb9e2d-88fa-4974-bb68-f31ba4031784" xlink:to="loc_dei_PreCommencementTenderOffer_81f57f25-d754-44a0-b579-202c9021d38e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_de30b439-8eb6-4fac-9133-5b4b52dcedc5" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f9eb9e2d-88fa-4974-bb68-f31ba4031784" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_de30b439-8eb6-4fac-9133-5b4b52dcedc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_949d7cfa-7977-445a-a360-26e29650d595" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f9eb9e2d-88fa-4974-bb68-f31ba4031784" xlink:to="loc_dei_Security12bTitle_949d7cfa-7977-445a-a360-26e29650d595" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_c7cb4773-9b82-48e7-ac4e-c6307bb83b1c" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f9eb9e2d-88fa-4974-bb68-f31ba4031784" xlink:to="loc_dei_TradingSymbol_c7cb4773-9b82-48e7-ac4e-c6307bb83b1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_62992f8c-0286-4821-a91e-6c4a5fca501b" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f9eb9e2d-88fa-4974-bb68-f31ba4031784" xlink:to="loc_dei_SecurityExchangeName_62992f8c-0286-4821-a91e-6c4a5fca501b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_62146eb0-748e-445d-ab35-09a5c4069922" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f9eb9e2d-88fa-4974-bb68-f31ba4031784" xlink:to="loc_dei_EntityEmergingGrowthCompany_62146eb0-748e-445d-ab35-09a5c4069922" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_2a07c0e2-b137-4698-9307-54c92f53a2db" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f9eb9e2d-88fa-4974-bb68-f31ba4031784" xlink:to="loc_dei_EntityCentralIndexKey_2a07c0e2-b137-4698-9307-54c92f53a2db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_0d682ccb-7597-4362-92a5-c8e2661ee104" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f9eb9e2d-88fa-4974-bb68-f31ba4031784" xlink:to="loc_dei_AmendmentFlag_0d682ccb-7597-4362-92a5-c8e2661ee104" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>imagea.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 imagea.jpg
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M$7HE1A(IV=*S3F/D@HKZ])RI2]",H"%>]D+8HN_0[!\#F)\M2B@%3X'-UB1
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C0 G:5<S7NL5 ,;"<@7\#D1Z)BC@)4Y0     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45203044376384">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Jan. 12, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jan. 12,  2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">EXAGEN INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-39049<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">20-0434866<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1261 Liberty Way<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Vista<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">92081<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">760<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">560-1501<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.001 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">XGN<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001274737<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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M:%0*CMQC)8QQ8K3^-8+)#^Q^ %!+ P04    "  20"U:JL0B%C,!   B @
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M-_=%KLWC":[?#'!X=/X!4$L#!!0    ( !) +5IED'F2&0$  ,\#   3
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M  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    "  20"U:)!Z;HJT   #X 0
M&@              @ &?$0  >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-0
M2P$"% ,4    "  20"U:99!YDAD!  #/ P  $P              @ &$$@
I6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     "0 ) #X"  #.$P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="exdx-20250112.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.exagen.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" original="exdx-20250112.htm">exdx-20250112.htm</File>
    <File>exdx-20250112.xsd</File>
    <File>exdx-20250112_lab.xml</File>
    <File>exdx-20250112_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "exdx-20250112.htm": {
   "nsprefix": "exdx",
   "nsuri": "http://www.exagen.com/20250112",
   "dts": {
    "inline": {
     "local": [
      "exdx-20250112.htm"
     ]
    },
    "schema": {
     "local": [
      "exdx-20250112.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "exdx-20250112_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "exdx-20250112_pre.xml"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 23,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 22
   },
   "report": {
    "R1": {
     "role": "http://www.exagen.com/role/Cover",
     "longName": "0000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exdx-20250112.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exdx-20250112.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.exagen.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.exagen.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.exagen.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://www.exagen.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.exagen.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.exagen.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.exagen.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.exagen.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.exagen.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.exagen.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.exagen.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.exagen.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.exagen.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.exagen.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.exagen.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.exagen.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Issuer Tender Offer",
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.exagen.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Tender Offer",
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.exagen.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.exagen.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.exagen.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Soliciting Material",
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.exagen.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.exagen.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Written Communications",
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001274737-25-000003-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001274737-25-000003-xbrl.zip
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M98[K_CC/6$W. 6<HR;(TE.^+K6!.-)O+PM7++-$+)WN?($DN_U;1?)K9Q$O
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M PPQW9IM7RW>H%# A"@%F*80$(HP8)Q%@!LHF,"A8<3\=/6&DC!.N+4(&:*
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MD!*$J\>HO.I<YUF# RET+?<1\6M(11W>5^%''&GGS.0ZETH1HV0D,C>.6*"
MH@AF0VZ\XOL)_8[97@SP\3/P=BT/#,/[JBF:AT^P*%HEJN87NX*YTY!EZ#KQ
M,0"14@-Q"#!!PA5WN>'*F$$LO&2U%PIBO"@,5G(4)%QB=I9NZ]0)_QGUAXOZ
MKFK2PT4=8&ZY%C9@_ST8AEF21I5$.][E/.<>( 2P>P#COW:B%R=R[)SL3^=1
M8/.A*.&7NY6#- =ME:+*$JU=ALB[2(SQE@C-@A<^9(ZQ/3#RU6(O(-38@7BC
M@J.(_HW=7 ;4JHC%XZ3CR9%<R,Q*)8C5&6)L,TM,C*TLCDFA(J*\C^'B%?.]
MN-!CYV(?VHX"DO,0, 3KIS^<L &;!P.9R$(DJLV19"8P1](B(SXWTF(O,JF&
M39->-=T+CFSL< S5=$Q@7.#FQW13WU=SX9W5.<7)5(@")U-*$Y-1]"B*W AT
M#]^#^\/BJ^%>4.3?"11OU'-,2'1YT<=TG>HO1>5A'IC.5 2!(QV71#+IB:$V
M(U%Q'0-SF;7[2"U>MMX+#O.=P#%$V3$1<EVO&UO^N[CMTN;HN(E,>Q(RJ8FD
MD9+<H5-*2R94B$88L3\^=FSW*V;1[P2/M\MZ8#C:0>\\@>WZS;0)&A-FPB W
M1$:?$>LL)T$Y3IG2$&PV"(=OK?4#8,3ES#=+=^"0MPL=Y?6RKK;3)\FCX9(:
MPF@(1'J!N!KGB5312,8R&YT;%/:_6NP7^A%7,0=)>.#P_Y:*IH'JHEZM[JJG
M*=)ZSA33 I@FE 8<LKS!W,=KCELZ: 40I/2#&'C1;#\01ES#'"[F@6GX7)>%
M+YJB6OR,"4XJ;#FG#(0WS+2S(!S*!,<MW"=*,"Z 1Q_TL(6-YS;[<3#B&N5
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M077T&"B(N./)Q.;@-5 E#<)*-8HG2S',>YKQ&>B^&^PDD)DR>- $G@.40RK
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M_,H>/)2?D8HCE.QO:(P#]+4*PD9&=KUS\.V!!P4ZOY8C3A=9HIHL:8M8*%
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MGJ/?PZ+&BZZ.)_!GX-+DU7\!4$L! A0#%     @ $D M6A3$A&4O$0  OGH
M !$              ( !     &5X9'@M,C R-3 Q,3(N:'1M4$L! A0#%
M  @ $D M6JE+SVM= @  \P8  !$              ( !7A$  &5X9'@M,C R
M-3 Q,3(N>'-D4$L! A0#%     @ $D M6C@7PX$."@  ?50  !4
M     ( !ZA,  &5X9'@M,C R-3 Q,3)?;&%B+GAM;%!+ 0(4 Q0    ( !)
M+5K?AI-PJ 8  -HP   5              "  2L>  !E>&1X+3(P,C4P,3$R
M7W!R92YX;6Q02P$"% ,4    "  20"U:RU,#Y.X6  "-A@  '@
M    @ $&)0  <')E<W-R96QE87-E+3(P,C1S96QE8W1P<F4N:'1M4$L%!@
0   %  4 4 $  # \      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>exdx-20250112_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="exdx-20250112.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001274737</identifier>
        </entity>
        <period>
            <startDate>2025-01-12</startDate>
            <endDate>2025-01-12</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-21">0001274737</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="c-1" id="f-22">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="c-1" id="f-1">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-2">2025-01-12</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="c-1" id="f-3">EXAGEN INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-4">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="c-1" id="f-5">001-39049</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-6">20-0434866</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-7">1261 Liberty Way</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-8">Vista</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-9">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-10">92081</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-11">760</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-12">560-1501</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="c-1" id="f-13">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="c-1" id="f-14">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="c-1" id="f-15">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="c-1" id="f-16">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="c-1" id="f-17">Common Stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-18">XGN</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-19">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-20">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
